chr16-30701000-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006662.3(SRCAP):​c.54+122C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00739 in 943,688 control chromosomes in the GnomAD database, including 312 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 189 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 123 hom. )

Consequence

SRCAP
NM_006662.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.300

Publications

0 publications found
Variant links:
Genes affected
SRCAP (HGNC:16974): (Snf2 related CREBBP activator protein) This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012]
SRCAP Gene-Disease associations (from GenCC):
  • developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Floating-Harbor syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-30701000-C-A is Benign according to our data. Variant chr16-30701000-C-A is described in ClinVar as Benign. ClinVar VariationId is 1304889.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006662.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRCAP
NM_006662.3
MANE Select
c.54+122C>A
intron
N/ANP_006653.2Q6ZRS2-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRCAP
ENST00000262518.9
TSL:2 MANE Select
c.54+122C>A
intron
N/AENSP00000262518.4Q6ZRS2-1
SRCAP
ENST00000411466.7
TSL:3
c.54+122C>A
intron
N/AENSP00000405186.3C9J4U4
SRCAP
ENST00000706321.1
c.54+122C>A
intron
N/AENSP00000516346.1Q6ZRS2-1

Frequencies

GnomAD3 genomes
AF:
0.0290
AC:
4405
AN:
152096
Hom.:
183
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00550
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.0182
GnomAD4 exome
AF:
0.00320
AC:
2535
AN:
791474
Hom.:
123
AF XY:
0.00266
AC XY:
1085
AN XY:
407842
show subpopulations
African (AFR)
AF:
0.101
AC:
2024
AN:
20046
American (AMR)
AF:
0.00462
AC:
156
AN:
33766
Ashkenazi Jewish (ASJ)
AF:
0.00142
AC:
27
AN:
18948
East Asian (EAS)
AF:
0.00131
AC:
43
AN:
32928
South Asian (SAS)
AF:
0.000176
AC:
11
AN:
62608
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45994
Middle Eastern (MID)
AF:
0.00136
AC:
6
AN:
4404
European-Non Finnish (NFE)
AF:
0.000108
AC:
58
AN:
535172
Other (OTH)
AF:
0.00558
AC:
210
AN:
37608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
106
211
317
422
528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0291
AC:
4435
AN:
152214
Hom.:
189
Cov.:
32
AF XY:
0.0282
AC XY:
2100
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.103
AC:
4293
AN:
41506
American (AMR)
AF:
0.00543
AC:
83
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68016
Other (OTH)
AF:
0.0180
AC:
38
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
202
404
605
807
1009
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0270
Hom.:
19
Bravo
AF:
0.0329
Asia WGS
AF:
0.00953
AC:
34
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.77
DANN
Benign
0.50
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73536499; hg19: chr16-30712321; API